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Microfluidic Chromatography for Early Stage Evaluation of
Biopharmaceutical Binding and Separation Conditions
Michael S. Shapiro,1 Stephen J. Haswell,2 Gary J. Lye,1 and Daniel G. Bracewell1
1The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering,
University College London, Torrington Place, London, UK
2Department of Chemistry, University of Hull, Hull, UK
Optimization of separation conditions for biopharmaceuticals
requires evaluation of a large number of process variables. To min-
iaturize this evaluation a microﬂuidic column (1.5 lL volume and
1 cm height) was fabricated and packed with a typical process scale
resin. The device was assessed by comparison to a protein separation
at conventional laboratory scale. This was based upon measurement
of the quality of packing and generation of breakthrough and
elution curves. Dynamic binding capacities from the microﬂuidic
column compared well with the laboratory scale. Microﬂuidic scale
gradient elution separations also equated to the laboratory column
three orders of magnitude larger in scale.
Keywords breakthrough; elution; ion exchange; microﬂuidics
INTRODUCTION
Ion exchange chromatography is a commonly used
separation process within the biopharmaceutical industry.
The charged stationary phase will interact, bind, and separ-
ate an oppositely charged macromolecule such as a protein
or DNA present in the mobile phase. Cation exchange
occurs where the stationary phase is negatively charged
and the macromolecule in the mobile phase has a net posi-
tive charge, while the opposite situation occurs in the case
of anion exchange chromatography (1,2). In assessing
chromatographic performance, plate analysis combined
with frontal and elution chromatography is commonly
used (2). Frontal chromatography (or breakthrough) is
the process by which the column becomes saturated with
the biological macromolecule contained within the mobile
phase, while elution chromatography involves the separ-
ation of solutes using a step or linear gradient, usually
via increased salt concentration (2).
Biopharmaceuticals represent an internationally impor-
tant and growing industry sector (3). This is especially
highlighted in the ﬁeld of chromatography where there
are an ever increasing number of stationary phase materials
available from suppliers each offering improved separa-
tions and recovery yields. During bioprocess development
biopharmaceutical companies generally have restricted
time and resources to analyse each of these resins for a
speciﬁc puriﬁcation process. Microﬂuidic scale chroma-
tography columns, requiring minimal quantities of resin
and product molecule, offer potential advantages in this
respect. Additionally, many experimental variables such
as protein concentration, buffer type, pH, ﬂowrate, etc.
may be investigated in systems that have the possibility
to be used in parallel and in Lab-on-a-chip formats. Possi-
bilities include sample preparation and eluate analysis on a
single microﬂuidic chip (4).
There have been a number of approaches described in
the literature recently to small-scale chromatography
evaluation. The majority relate to 96-well microtiter ﬁlter
plate technologies (micro-batch adsorption) (5) as well as
resin-packed micro-pipette tips (micro-tip columns) (6,7).
Additionally, more conventional mini columns have also
been described (8). In each case parallelization of exper-
imentation is achieved by integration with a laboratory
liquid handling robot. Fig. 1 summarizes the available
technologies (9) and also compares the scales of operation
to the microﬂuidic approach established here.
Micro-batch adsorption is operated using a batch mode
such that the resin is contained within the microwell plate
while the remaining liquid is captured by using aspiration
or ﬁltration. Linear gradients cannot be performed using
this technique; however, pseudo linear gradients have been
developed using a series of increasing ionic strength batch
adsorption steps (10). This approach has been applied to
both breakthrough and elution chromatography yielding
results that can compare favorably with laboratory scale
columns (11–15). Micro-pipette tip systems also operate
in batch mode; however, the solute containing ﬂuid is
moved in both directions through the resin bed by repeated
automated aspiration and dispensing of the sample. This
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approach offers enhanced solute mass transfer under
ﬂow conditions and we have recently demonstrated its
application to the miniaturization of virus-like particle
puriﬁcation (6). The more conventional mini columns
(50, 100, 200 mL) resemble most closely standard labora-
tory chromatography columns. They are operated as part
of a 96 microwell plate system where the mobile phase is
pumped through the column in one direction. Such systems
have been successfully used for the determination of
dynamic binding capacity and elution chromatography of
proteins (8).
While offering certain advantages none of these technol-
ogies truly operate as a chromatography column offering
continuous mobile ﬂow with either linear or gradient elu-
tion. Previously, we described the fabrication and ﬂow
characterization of a microﬂuidic chromatography column
that has the necessary ﬂow characteristics and which oper-
ates at at least a 20,000-fold smaller scale than standard
laboratory scale columns. Dynamic binding capacities were
generated that were comparable with those found within
the literature (16) for laboratory scale columns. In this
work study of the 1.5 mL microﬂuidic column is extended
to both dynamic binding and separation studies with model
protein solutions of either lysozyme or a mixture of hen egg
white proteins. The column is packed with a polydisperse
6% agarose process resin, Sepharose 6FF, in order to
resemble the columns used in the ultimate large scale appli-
cations. In this way the work is distinct from the small scale
columns used in proteomics studies which are based on
very small, monodisperse resins and which separate only
digested protein fragments rather than whole proteins
(17). When compared to results obtained on conventional
laboratory scale columns the microﬂuidic column shows
almost quantitiative agreement in dynamic binding capa-
city and gives a good indication of separation conditions.
MATERIALS AND METHODS
Materials
All chemicals were purchased from Sigma-Aldrich
(Dorset, UK), apart from the ﬂuorescein-5-isothiocyanate
(FITC) which was purchased from Invitrogen (Paisley,
UK), and were of the highest purity available. The chroma-
tography resins, Sulfopropyl (SP) and Quaternary Amine
Sepharose (Q) Fast Flow, were bought from GE Health-
care UK Ltd (Buckinghamshire, UK). Chicken eggs were
purchased locally from Tesco (London, UK). All tubing,
the connectors and the MilliGAT pump, were purchased
from Presearch (Hampshire, UK). All buffers were
prepared using analytical grade water (Millipore, Watford,
UK).
Packing and HETP Measurements for the Laboratory
Scale Columns
The 2 or 30mL columns of Q or SP Sepharose Fast
Flow (6% agarose) were gravity settled and ﬂow packed at
a velocity of 300 cm h1 into an XK 16=20 Column to a
height of 15 cm. To gravity pack, the bottom adaptor was
placed on the bottom of the XK column then 30–35mL of
SP Sepharose Fast Flow in 20% (v=v) ethanol was poured
into the column. The adaptor was opened to allow the
ethanol to drip out. More matrix was then gently poured
into the top of the column to ensure the height reached
17 cm. Once the matrix had formed a stable bed, the bottom
adaptor was sealed and further addition of 20% (v=v)
ethanol was added to the top of the column until a meniscus
was formed. The top adaptor was connected to an AKTA
Basic (GE Healthcare) and was placed at a 45 angle onto
the top of the bed. Then, using a ﬂowrate of 0.5mL min1
of ethanol to avoid air bubbles, the bottom adaptor was
opened to ready the column for ﬂow packing. The ﬂowrate
was slowly increased to 10mL min1 (300 cm h1) until
the column had compressed to 15 cm, then the top adaptor
was placed on top of the bed. The packing quality was
then tested by producing a conductivity peak using a
100mL sample loop ﬁlled with 2M NaCl at 0.5mL min1.
The HETP and asymmetry of the peak were then calculated.
FIG. 1. A selection of the microscale chromatography technologies cur-
rently available. The ﬁrst three are designed for use with a laboratory
automation platform, while the fourth is the microﬂuidic chip presented
here.
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Laboratory Column Breakthrough Measurements
Each SP Sepharose 6FF column was equilibrated with 5
Column Volumes (CVs) of 0.05M sodium phosphate
buffer pH 5.5 (start buffer). This buffer system was selected
to have a large buffering pH range; however, at pH 5.5 it is
limited, and to ensure capacity results were not impacted
by this selection they were validated against a sodium acet-
ate system. Lysozyme (1mgmL1) from egg white in the
same buffer was continually pumped through at either 9,
7.5, 5, or 2mLmin1 (270, 225, 150, and 60 cmh1 calcu-
lated on the basis of an XK 16=20 column). When break-
through was achieved, the column was washed with 5
CVs of the start buffer, and then the lysozyme was eluted
from the column using 5 CVs of 0.05M sodium phosphate
and 1M NaCl buffer (elution buffer) at the same pH. The
column was then regenerated with 5 CVs of 1M sodium
hydroxide and equilibrated with the start buffer. Dynamic
binding capacity was then calculated at 5, 10, and 100%
capacity by calculating the area under the breakthrough
curve, subtracting the mass of protein adsorbed from that in
the feed and then dividing the result by the column volume.
Laboratory Column Elution Measurements
Egg white was separated from the egg yolk and 1 in 2
diluted using 0.05M Tris=HCl pH 8. The mixture was stir-
red overnight at 4C to remove glycosylated proteins
by precipitation, then centrifuged at 10000RPM for
30 minutes (18–20).
Each Q Sepharose 6FF column was equilibrated with 5
CVs of 0.05M Tris=HCl pH 8 and then run isocratically at
2, 5, 7.5, or 9mL min1 (linear velocities of 60, 150, 220,
and 270 cmh1). For the 2mL column, injection volumes
of 0.13, 0.33, 0.67, and 1.33mL were used while for the
30mL column, volumes of 2, 5, 10, and 20mL were used.
Two CVs were used for the injection process using either
standard loops with PEEK tubing or for larger volumes,
a superloop. The superloop is a pressurized cylinder which
can be connected to the pump as a standard loop. It is used
for injections of 10mL and above. Fifteen CVs were used
for the linear gradient based on 0.05M Tris=HCl, 0.3M
NaCl pH 8 and then 5 CVs were used for the ﬁnal wash
step in which the elution buffer was used. The column
was then re-equilibrated for 5 CVs using 0.05M Tris=
HCl pH 8. Experiments were also performed using a linear
gradient of 0.05M Tris=HCl, 0.3M NaCl pH 8 over 150
CVs to facilitate comparison with the microﬂuidic column
results.
Microfluidic Column Fabrication and Operation
Details of microﬂuidic column fabrication are described
in our previous work (16). Brieﬂy, the glass chip was fabri-
cated using standard photolithography and wet etching
techniques. The column length, width, and depth were
constant at 10mm, 1000 mm, and 150 mm. The packing pro-
cedure involved the dilution of a 20% (v=v) slurry of resin
in 20% (v=v) aqueous ethanol. Beads were sieved using 38
and 106 mm (VWR Leicestershire, UK) mesh to reduce the
size range in order to prevent blockages. Beads were
packed into the microﬂuidic column using a 2mL plastic
syringe with an adapted micropipette tip. The matrix was
manually pressurized into the packing chamber and held
in position due to a keystoning effect. The quality of the
packed microﬂuidic column was then checked using a Leica
DMRA2 microscope (Leica Microsystems, Milton Keynes
UK) and QWin Software to ensure that there were no
resin particles that blocked the inlet and outlet channels.
MilliGAT pumps were used throughout this work in the
experimental setup outlined in Fig. 2. These pumps are able
to accurately pump from 0.66 106 mL min1 and can
accurately dispense 10 mL of liquid. A small internal
volume Rheodyne Valve was used for all injections into
the microﬂuidic column.
FIG. 2. Schematic diagram of the experimental system used for microﬂuidic elution chromatography. Two precision MilliGAT pumps were used to
pump the start buffer (0.05M Tris=HCl pH 8) and elution buffer (0.05M Tris=HCl=0.3M NaCl pH 8) through the nanomixer and injection valve and
into the microﬂuidic column containing Q Sepharose FF beads. A sample of 1mL of 1mgmL1 lysozyme, 3.6mgmL1 conalbumin and 15mgmL1
ovalbumin in start buffer was injected onto the microﬂuidic column once equilibrated with start buffer (20% (v=v) of each protein was ﬂuorescently
labelled using FITC).
OPTIMIZING SEPARATION CONDITIONS FOR BIOPHARMACEUTICALS 187
D
ow
nl
oa
de
d 
by
 [D
ea
kin
 U
niv
ers
ity
 L
ibr
ary
] a
t 2
0:0
8 1
9 J
an
ua
ry
 20
14
 
All protein solutions contained 20% (v=v) of the protein
ﬂuorescently labelled using ﬂuorescein-5-ithocyanate
(FITC). The preparation of the ﬂuorescently labelled pro-
teins was performed using the manufacturer’s instructions
with slight modiﬁcations (21) as described previously
(16). Leica QWin software was used as the image analysis
software where ﬂuorescence quantiﬁcation was analyzed
by altering the resolution time depending on the level of
ﬂuorescence. A time interval programe was developed to
record the average ﬂuorescence intensity in the outlet
channel every 3 seconds (16).
Breakthrough measurements occurred using 1mgmL1
lysozyme in 0.05M sodium phosphate buffer pH 5.5 (start
buffer). The buffer was pumped at linear velocities of
60, 150, 220, and 270 cm h1 (1.33, 3.67, 5.33, and
6.67 mL min1 respectively) calculated for the microﬂuidic
packed bed using the crosssectional area of the column.
Column dead volume was analyzed using 1mgmL1
lysozyme in 0.05M Tris=HCl pH 8 using Quarternary
amine (Q Sepharose FF) beads. Dynamic protein binding
capacity was calculated at 5, 10, and 100% breakthrough.
All data was normalized in terms of c=co where c is the
lysozyme concentration in the efﬂuent at each time point
and c0 is the highest value of recorded efﬂuent concen-
tration. Equation (1) was used to calculate the binding
capacity (Q) (22):
Q ¼
Min  Vretained
R co
cin
dc
 
Vbeads
 em
es
ð1Þ
Here Min is the total protein mass into the column,
Vretained and Vbeads are the volume retained through the sys-
tem and the volume of the beads packed in the column
respectively and es and em are the voidages in a standard
column and in the microﬂuidic column respectively. The
voidage was normalized in this way to allow comparison
with larger scale published results. Data presented is the
average of at least three breakthrough curves determined
at different ﬂowrates.
Microfluidic Column HETP Measurements
The experimental procedure used was the same as for
the breakthrough measurements, except the ﬂuorescent
light microscope detection occurred at either end of the
microﬂuidic column which now contained sieved Q Sephar-
ose Fast Flow beads (average diameter of 70 mm). The vari-
ance and HETP (23) were then calculated from the
intensity readings produced. A volume of 0.4 mL (the smal-
lest volume available) of 1mgmL1 lysozyme (20% (v=v)
ﬂuorescently labelled) in 0.05M Tris=HCl pH 8 was
injected into the microﬂuidic column. The method was
validated against the laboratory scale method described
earlier to ensure no interactive effects between the protein
and column.
Microfluidic Column Elution Measurements
A 1.5 mL microﬂuidic column packed with sieved Q
Sepharose Fast Flow was equilibrated with 5 CVs of
0.05M Tris=HCl pH 8 (start buffer). A concentration of
1mgmL1 lysozyme, 3.6mgmL1 conalbumin, and
15mgmL1 ovalbumin proteins (20% (v=v) of each
labelled with FITC) was pumped through in the start
buffer. Elution was carried out using the same method out-
lined in the laboratory column elution measurements. The
peaks were monitored using the Leica ﬂuorescent micro-
scope as shown in Fig. 2. In order to achieve the gradient,
0.2mgmL1 ﬂuorescently labelled lysozyme was used in
place of the elution buffer allowing the monitoring of the
gradient using the Leica microscope. The gradient used
for the separations was 0.05M Tris=HCl pH 8 with
0.3M NaCl over 150 CVs over 16 step changes.
RESULTS AND DISCUSSION
Determination and Assessment of Column Packing
Initial experiments focused on measurement of the
HETP of the three columns in order to assess the quality
of resin packing. The HETP for the 30mL (15 cm height)
and 2mL (1 cm height) columns were calculated to be
389.9 and 350.7 mm at a linear velocity of 30 cm h1 while
the variance (r2) for each was 1.83 and 0.10mL2. The vari-
ance for the 2mL column gave a lower plate number due to
the reduced height and increased complexity involved in
packing the column. The asymmetry of the 30 and 2mL
columns were 0.65 and 2 respectively. Ideal peak symmetry
should be achieved for a well-packed chromatography
column. The values reported here display under and over
packing respectively; however, the results produced were
adequate for comparisons with the microﬂuidic column
(24).
Table 1 displays the measured peak asymmetry, the
calculated variance of the peak, the HETP and the
HETP=dp (diameter of the resin particle) as a function of
mobile phase linear velocity for the 1.5 mL microﬂuidic col-
umn. Values were calculated from the width at 50% of the
maximum height of the peak using the standard plate
analysis (23). Although the peaks used for analysis were
not Gaussian, due to tailing, standard peak analysis was
considered useful as a method to compliment the confocal
microscopy analysis developed previously 16. The asym-
metry values for all peaks were two to three times the value
of a Gaussian peak (unity). The variance calculated over
the column was smaller than expected since laminar ﬂow
and diffusive mixing throughout the extra-column system
appear to be the dominating factor. The volume of the
adjacent equipment was 2 mL, compared to the volume of
the packed bed which was 1.5 mL, producing dispersed
peaks. The data presented, however, does show that
variance and HETP may still be calculated within a
188 M. S. SHAPIRO ET AL.
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microﬂuidic system. In Table 1, r2 can be considered to be
constant at around 1.5 106mL2.
The HETP data are also presented in Table 1. As the
variance is directly proportional to the HETP (23) a similar
level of error is observed. The value for the HETP can be
considered to be around 1mm, while the HETP=dp is
around 14. In conventional terms, this value would be
indicative of poor packing especially when compared with
the laboratory scale 15 cm column (experimentally determ-
ined to have a HETP=dp of 4). However, the 2mL column
produced a similar value to the microﬂuidic column due to
similar heights.
The voidage in the microﬂuidic column was 0.55 (as
calculated and presented previously (16)) which implies
that there are more voids present in the microﬂuidic packed
system than in a standard column. When considering the
assessment of microﬂuidic column packing the plate test
results are best interpreted in conjunction with a three
dimensional image of the packing, as shown within Fig. 3.
In practice the packing was good enough for the binding
and elution studies given that there was only 1.5 mL of
packing and that on average it is only 2 beads high.
Laboratory Scale Column Breakthrough Profiles
As a basis for later comparison with the microﬂuidic
column, Fig. 4 displays the breakthrough curves for all 4
ﬂowrates as a function of the volume retained for (a) the
30mL (15 cm height) column and (b) the 2mL (1 cm
height) column. Breakthrough curves for the 30mL col-
umn (Fig. 4(a)) are consistent and independent of mobile
phase linear velocity. They show near perfect representa-
tions of breakthrough curves with a constant pattern front
(25,26). This was expected and is due to a number of
factors including the use of low concentrations of a model
protein and the fact that lysozyme is a protein with a high
isoelectric point (11.1) that adsorbs with high afﬁnity (27).
For the 2mL column (Fig. 4(b)) there is some variation
of the breakthrough curves with increasing linear velocity;
however, in general the ﬂow rates are consistent. At the
higher ﬂowrates the residence time in the column would
be reduced leading to proportionally less time for the pro-
tein to interact with the matrix particles. Additionally, as
shown in Table 2 there was a decreased number of theoreti-
cal plates. However, the breakthrough curves are highly
consistent and accurate over the range required.
The breakthrough curves determined here in both the
laboratory scale columns are similar to those described in
the literature (28,29) using lysozyme with the same Sephar-
ose FF resin. The reported values of maximum dynamic
binding capacity were also similar to those calculated and
reported here in Table 1 (120mgmL matrix1).
Microfluidic Scale Column Breakthrough Profiles
In our previous work on chip fabrication and analysis of
ﬂuid ﬂow within the column initial breakthrough studies
TABLE 1
Inﬂuence of mobile phase linear velocity on microﬂuidic chromatography column performance. Peak symmetry,
r2 and the HETP and HETP/dp determined using 0.4 mL of 0.2mgmL
1 ﬂuorescently labelled lysozyme in 0.05M
Tris=HCl buffer pH 8 (non-binding conditions). Asymmetry and r2 were calculated from the values obtained before
and after the packed microﬂuidic column. Errors represent one standard deviation around the mean
Linear velocity (cm h1) r2 (mL2) HETP (mm) HETP=dP Asymmetry
60 1.41 106 4.35 107 945 290 13.52 4.16 2.98 0.56
105 1.44 106 1.70 107 1050 175 15.00 2.52 2.64 0.31
150 1.21 106 0 1035 35.30 14.79 0.50 2.90 0.36
220 1.09 106 2.74 107 970 95.80 13.88 1.37 3.05 0.30
270 1.12 106 0 1010 0 14.44 0 3.10 0.22
FIG. 3. Confocal microscope image of a section of the microﬂuidic
packed bed rendered in a 3 dimensional plane. The perspective is of a
45 angle from the top of the bed (average particle diameter 70 mm).
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on the microﬂuidic column were also reported. Here
comparisons are made between breakthrough proﬁles
determined on the microﬂuidic column and the two
laboratory scale columns at an identical linear velocity of
270 cm h1. The voidage for the 1.5 mL column was 0.55
as opposed to 0.4 which was present in the standard lab-
oratory columns (as is also standard in general chromato-
graphy columns) (16). Instead of the standard column
volumes employed in previous ﬁgures, the resin column
volumes was used where the column volume was multiplied
by the bed voidage, so as to standardize the results.
As shown in Fig. 5, the microﬂuidic and the 2mL lab-
oratory scale columns are very similar in terms of break-
through proﬁle shape and the column residence time.
This agreement is considered excellent given the 1300-fold
difference in scale and is probably related to the columns
having the same length. The breakthrough curve for the
30mL column is a near perfect representation of a break-
through curve which was considered to be an excellent
basis to make comparisons with other scales.
Table 2 presents a comparison of the calculated
maximum and 5% dynamic binding capacities for both
laboratory scale columns and the microﬂuidic column at
different mobile phase linear velocities. Values of the
maximum binding capacity are in reasonable agreement
between the microﬂuidic and laboratory scale, as suggested
by the breakthrough proﬁles shown in Fig. 5. Although the
shape of the breakthrough curve was different, the calcu-
lated maximum binding capacity for the 30mL column
was similar to the microﬂuidic column.
Calculated dynamic binding capacities (at 5% capacity)
were not as similar between the various scale columns as
were the maximum binding capacities. This may have been
due to non-speciﬁc binding and channelling through the
column (16). Overall, the capacities calculated are in
reasonable agreement with previously published data and
laboratory scale data (28,29). This provides a further con-
ﬁrmation that the microﬂuidic chromatography column
does offer a useful methodology for the determination of
breakthrough curves and binding capacities using consider-
ably reduced quantities of material.
FIG. 4. Inﬂuence of mobile phase velocity on dynamic binding capacity
of laboratory scale chromatography columns. Breakthrough curves of
1mgmL1 lysozyme using (a) 30mL (15 cm height) and (b) 2mL (1 cm
height) XK 16=20 columns containing SP Sepharose Fast Flow in
0.05M sodium phosphate pH 5.5.
TABLE 2
Comparison of maximum and 5% dynamic binding capacities for the microﬂuidic and laboratory scale columns
Linear velocity (cm h1)
Dynamic binding capacity
(mgmL matrix1)
1.5 mL Column 2mL Column 30mL Column
60 150 220 270 60 150 220 270 60 150 220 270
5% 140 144 50.3 55.7 79.8 57.3 53.5 39.6 105 105 103 103
Maximum 160 175 96.4 117 116 121 113 108 116 112 104 111
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Laboratory Scale Column Elution Profiles
Figure 6 displays the egg white separation data gener-
ated using the two laboratory scale columns. Three peaks
are clearly shown in each proﬁle, the ﬁrst being lysozyme,
which is unretained, and two further peaks which are not
fully resolved. In Fig. 6(a) for the 30mL column conalbu-
min and ovalbumin represent the second and third peak
respectively. There is some evidence that resolution using
smaller injection volumes produced better resolution, as
the column has sufﬁcient time to remove the proteins over
the linear gradient. In Fig. 6(b) when using 1.33mL as the
injection volume for the 2mL column, no resolution was
obtained between the second two peaks. This is almost
certainly due to the reduction in the residence time in this
much shorter column. The lack of resolution on both
columns could be due to the fact that the isoelectric points
for both proteins are comparatively close to each other.
Conalbumin has a pI of 6.5, while ovalbumin has a pI of
4.7 (30) which could lead to some competitive binding. A
longer bed height or a longer linear gradient would most
likely improve resolution of the two proteins when using
the same ﬂowrates. The fact that there was incomplete res-
olution between peaks, however, does not detract from the
ability to obtain useful insights from these columns on how
the conalbumin-ovalbumin peaks alter with changing bed
heights and potentially different mobile phase conditions
i.e., pH, ionic strength etc.
Microfluidic Scale Elution Profiles
In assessing the utility of the microﬂuidic column in
early stage bioprocess development it is important to not
only assess binding capacity (Table 2) but also the degree
of resolution that could potentially be obtained on the ulti-
mate, large scale manufacturing column. One of the main
technical challenges of achieving linear gradient separa-
tions at this scale is the production of the gradient. This
could be due to local ﬂow instabilities at nano ﬂowrate
changes explained below.
To visualize the linear gradient required for separation,
ﬂuorescently labelled lysozyme was used as buffer B instead
of a salt gradient. Results were then overlaid over the separ-
ation data. Separation of egg white proteins was then insti-
tuted. Column volumes in this case were not quoted in
terms of the resin column volume because the comparison
required referred to the linear gradient of the separation
which was not present when using breakthrough curves.
FIG. 6. Inﬂuence of mobile phase velocity on laboratory scale separation
of a ternary protein mixture. (a) a 20mL injection of 30mgmL1 egg
white proteins (3.6% (w=w) lysozyme, 12% (w=w) conalbumin and 54%
(w=w) ovalbumin) in 0.05M Tris=HCl buffer pH 8 using a 30mL column;
(b) 1.33mL injection of egg white protein using a 2mL column. The ﬁrst
peak is lysozyme, then conalbumin and ﬁnally ovalbumin. Proteins were
eluted using 0.05M Tris=HCl=0.3M NaCl pH 8 and the resin used was
Q Sepharose Fast Flow.
FIG. 5. Comparison of lyoszyme breakthrough curves determined on
the 1.5 mL (1 cm height) and 2mL (1 cm height) microﬂuidic chromato-
graphy columns compared to the laboratory scale 30mL (15 cm height)
column. Experiments performed at a linear velocity of 270 cmh1. Note
the 1300 fold difference in scale.
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To institute a linear gradient at the microﬂuidic ﬂowrates
used here, nano ﬂowrate changes are required. Very low
ﬂowrate changes are difﬁcult tomaintain as they are affected
by factors such as temperature, variation in the piston seal
quality over time, and there may be solvent compressibility
problems (31). Extremely small air bubbles in the liquid that
compress in a piston based pump could also cause instabil-
ities within local velocities. Velocities then even out as the
pressure reaches atmospheric pressure at the exit (32). The
small scale of the microﬂuidic column therefore ensures that
accurate gradients are difﬁcult to obtain. The chip version
developed by Brennen et al. (31) have developed gradients
over minutes at nano-liter ﬂow rates.
Irrespective of these technical challenges however, a
separation of three proteins using a linear gradient was
achieved on the microﬂuidic column as shown in Figs. 7
and 8. Figure 7 shows elution of the non-biding lysozyme
peak ﬁrst followed by a broader second peak being a
mixture of conalbumin and ovalbumin. There is a shoulder
evident on this second peak (at around 100 column
volumes), which is most likely to be from conalbumin while
the main body of the peak is ovalbumin.
Figure 8(a) provides a close-up view of this shoulder and
peak. In order to verify if the degree of separation achieved
is likely to be representative of large scale separations, it
was necessary to generate comparative 2mL column data
(i.e., 1 cm length at the laboratory scale) using a similar
150 column volume gradient as shown in Fig. 8(b).
Although the height of the conductivity when the curve
returns to the baseline differs between the scales, the length
of the gradient is the same.
Although full resolution was not observed between the
conalbumin and ovalbumin peaks when using 150 column
volumes with the 2mL column, the data in Figs. 7 and 8
represents a ﬁrst step in the generation of elution proﬁles
of ion exchange chromatography using a microﬂuidic
column.
Comparison with Other Microscale
Chromatography Techniques
As shown in Fig. 1 the performance and potential indus-
trial application of the microﬂuidic column established
here needs to be considered against other similar technolo-
gies for high throughput chromatographic process screen-
ing. The other systems presented use complex liquid
handling systems facilitating the use of many different
chromatographic separations at once. The advantage of
the approach presented within this paper is the use of
extremely small volume (1.5 mL) chromatography columns.
The microﬂuidic system is capable of developing into the
use of highly parallel chromatography columns using true
ﬂowrate conditions. All other systems within the literature
FIG. 7. Inﬂuence of mobile phase linear velocity on separation of a ter-
nary protein mixture. A microﬂuidic column egg white protein separation
using a series of 16 steps to produce a gradient over 150 column volumes.
The same buffer conditions were used as in the standard scale chromato-
graphy column system. An injection of 1mL volume was used containing
1mgmL1 lysozyme, 3.6mgmL1 conalbumin and 16.2mgmL1 ovalbu-
min in a ﬂuorescently labelled solution with the standard buffer.
FIG. 8. Comparison of both scales of the ternary protein separation at
the elution stage using 150 column volumes. Linear gradient separation
of the three egg white proteins using (a) the microﬂuidic column and (b)
the 2mL column. Both columns were run at 270 cmh1, while the injec-
tion volume used for the 2mL column was 1.33mL.
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operate using batch conditions or with the use of pseudo
linear gradients. The advantage of the microﬂuidic system
is that it is capable of producing separations using true
linear gradients as well as parallel conditions.
CONCLUSIONS
The data presented here displays positive initial results
on the performance of a 1.5 mL microﬂuidic chromato-
graphy column packed with process scale chromatography
resin. Results in terms of packing quality and performance
(HETP) and frontal and elution chromatography between
the microﬂuidic column and laboratory scale 2mL and
30mL columns showed good quantitative agreement both
in terms of maximum dynamic binding capacity and also
separation of binding and non-binding proteins. Protein
requirement has decreased 10,000-fold for breakthrough
analysis and 3000-fold for elution between the microﬂuidic
and the 30mL column. Therefore the work described in
this paper is representative of the proof of principle of a
potentially powerful tool for the generation of microﬂuidic
process bed data for the biopharmaceutical industry and is
useful for early stage bioprocess development.
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